Do you want to read an article? Please log in or register.
Overdiagnosis in low-dose CT lung cancer screening: A systematic review and meta-analysis of overall magnitude and subgroup variations
Lung, Respiratory and Thoracic Cancer
Related content
Lung, Respiratory and Thoracic Cancer
Low dose computed tomography for lung cancer screening in Tuberculosis endemic countries: A Systematic Review and Meta-analysis
J Thorac Oncol
Damaraju V, Krushna Karri JK, Gandrakota G, Marimuthu Y, Ravindra AG, Aravindakshan R, Singh N
doi: 10.1016/j.jtho.2024.11.020
Lung, Respiratory and Thoracic Cancer
Prevalence of osimertinib-induced cardiotoxicity in non-small cell lung cancer patients: a systematic review and meta-analysis
Lung Cancer
Gawli CS, Patil BR, Nagpure NR, Patil CR, Kumar A, Patel HM
doi: 10.1016/j.lungcan.2025.108629
Gynecologic Cancer
Compliance Rate With Triage Test and Treatment for Participants Screening Positive in Cervical Cancer Screening Programs: A Systematic Review and Meta-analysis
Obstet Gynecol
Wang M, Maimaitiming M, Bi Y, Jin Y
doi: 10.1097/AOG.0000000000005723
Lung, Respiratory and Thoracic Cancer
Evaluating the safety of antibody-drug conjugates in lung cancer: A systematic review and meta-analysis
Lung Cancer
He Q, Jiang L, Xu Y, Wang M
doi: 10.1016/j.lungcan.2025.108425
Lung, Respiratory and Thoracic Cancer
Occupational Benzene Exposure and Lung Cancer in Human Studies: A Systematic Review and Meta-Analysis
Environ Health Perspect
Wan W, Peters S, Portengen L, Babigumira R, Stenehjem JS, Richardson D, Vermeulen R
doi: 10.1289/EHP15086
Lung, Respiratory and Thoracic Cancer
Efficacy and safety of targeted therapy combined with anti-angiogenesis treatment in brain metastases of non-small cell lung cancer: a systematic review and meta-analysis
Lung Cancer
Pan Y, Gu Q
doi: 10.1016/j.lungcan.2025.108532
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Tasoudis P, Loufopoulos G, Manaki V, Doerr M, Agala CB, Long JM, Haithcock BE
doi: 10.1016/j.lungcan.2024.107929
Further Publications
LATE-STAGE OUTCOMES AS SURROGATES FOR MORTALITY IN CANCER SCREENING TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Cancer Epidemiol Biomarkers Prev
Rebolj M, Brentnall AR, Geppert J, Kouppa N, Shinkins B, Freeman K, Stinton C, Randell MJ, Johnson S, Smith RA, Sasieni P, Janes SM, Etzioni R, Duffy SW, Taylor-Phillips S
doi: 10.1158/1055-9965.EPI-25-0201
Lung, Respiratory and Thoracic Cancer
Systematic review and network meta-analysis of lorlatinib with comparison to other anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) as first-line treatment for ALK-positive advanced non-smallcell lung cancer (NSCLC)
Lung Cancer
Ou SH, Kilvert H, Candlish J, Lee B, Polli A, Thomaidou D, Le H
doi: 10.1016/j.lungcan.2024.107968